PRTA - Prothena jumps on report company may explore a potential sale
2023-10-16 09:48:02 ET
More on Prothena
- Prothena: Switching From 'Hold' To 'Buy' On Lead Alzheimer's Drug Promise
- Prothena (PRTA) Investor Presentation - Slideshow
- Prothena: Dunn Appointment And Bristol Opt-In Boost Validation
- Alzheimer's drug developers get lift from Anavex results
- Seeking Alpha’s Quant Rating on Prothena
For further details see:
Prothena jumps on report company may explore a potential sale